Alex Dean

Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis

Discussion created by Alex Dean on Mar 20, 2018

In recent years, the use of one or more conventional synthetic disease-modifying antirheumatic drugs has been recommended for the treatment of rheumatoid arthritis (RA). We performed a 52-week study on the efficacy and safety of iguratimod (IGU) against patients with RA in daily clinical use.

Outcomes